Schedule 13G ownership disclosure
CLEVELAND BIOLABS INC
Security class unavailable · CUSIP: 185860202
Event date: 2019-05-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 773,931
- Percent of class
- 6.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000940780-20-000005
- Form type
- SC 13G
- Filer
- Statera Biopharma, Inc.
- CIK
- CIK 1318641
- Filed
- Jan 24, 2020
- Reporting period
- May 14, 2019
- Description
- Schedule 13G beneficial ownership